FRESNO, Calif., Might 27, 2021 /PRNewswire/ — Integrated Prescription Management (IPM), a number one pharmacy advantages administration (PBM) firm, now presents pharmacogenomics testing for sufferers affected by melancholy or nervousness. The GeneSight® take a look at, provided by Myriad Genetics, Inc. (NASDAQ: MYGN), a pacesetter in genetic testing and precision medication, helps clinicians and sufferers higher perceive how a selected particular person might reply to sure medicines.
GeneSight is a psychotropic take a look at that analyzes how an individual’s genes impression how they could break down or reply to medicines generally prescribed to deal with melancholy, nervousness, and different psychiatric situations. Now, with a easy cheek swab, clinicians can be taught which medicines might require dose changes, be much less prone to work, or have an elevated danger of unintended effects primarily based on an individual’s genetic make-up.
“Pharmacogenomics is a game-changing worker profit,” mentioned Wealthy Adams, president and chief working officer at IPM. “Think about figuring out how you will react to a selected medicine earlier than you even take it. This know-how might eradicate weeks of taking a prescription that does not work – saving folks time, serving to them really feel higher sooner, and enhancing productiveness.”
Anxiousness and melancholy are the most typical psychological well being issues within the U.S., with greater than 18 percent of adults affected by nervousness and practically eight percent having skilled a depressive episode. Within the final yr, the variety of folks on the lookout for assist with these issues has dramatically elevated due the COVID-19 pandemic, with emotions of isolation, stress, and disappointment growing in all ages group.
“With correct remedy, individuals who endure from melancholy or nervousness can get higher,” mentioned Alex Habibe, MD, IPM’s medical director. “Taking the precise prescription medicine, mixed with cognitive behavioral remedy, is confirmed to be extremely efficient in serving to folks get their lives again.”
IPM additionally works with Myriad Genetics to supply Vectra® for rheumatoid arthritis. Vectra is a complicated blood take a look at that helps physicians perceive the extent of sufferers’ irritation, predict the danger of everlasting joint injury, and decide the suitable course of remedy.
Built-in Prescription Administration (IPM) is a full-service, center market PBM that works with self-funded employer teams, brokers, TPAs, and behavioral well being facilitates across the nation. Based in 2009, IPM offers high-touch service, insightful analytics, and strategic cost-management options. The corporate earned a Silver Stevie Award for Buyer Service Division of the 12 months and is a four-time honoree on Inc. 5000’s Listing of Quickest Rising Personal Corporations. IPM is headquartered in Fresno, CA with regional places of work in Dallas, TX and Atlanta, GA.
About Myriad Genetics
Myriad Genetics Inc. is a number one genetic testing and precision medication firm devoted to advancing well being and wellbeing for all, empowering people with very important genetic insights and enabling healthcare suppliers to higher detect, deal with and stop illness. Myriad discovers and commercializes genetic assessments that decide the danger of growing illness, precisely diagnose illness, assess the danger of illness development, and information remedy choices throughout medical specialties the place genetic testing can considerably enhance affected person care and decrease healthcare prices. For extra data, go to www.myriad.com.
Vice President, Advertising
Built-in Prescription Administration (IPM)
email@example.com | 559.612.6205
View unique content material to obtain multimedia:http://www.prnewswire.com/news-releases/ipm-launches-genesight-pharmacogenomics-program-for-depression-and-anxiety-301301028.html
SOURCE Built-in Prescription Administration